The short answer
There is not enough exact-pair clinical evidence in the checked sources to say that copper supplements reduce oral delafloxacin absorption or require a particular interval. Copper belongs to a group of metals that can bind medicines, but that possibility alone does not establish a clinical interaction with this antibiotic.
What this answer covers
Oral copper supplements with delafloxacin meglumine tablets. Copper salt, amount and other ingredients remain part of the assessment; another fluoroquinolone is not a substitute.
- Supplement or preparation
- Copper
- Medication ingredient
- delafloxacin
Why is an interaction considered possible?
The BAXDELA interaction section discusses binding between fluoroquinolones and certain metal ions. That supplies a general mechanism to investigate, but it is not a clinical test of copper. The amount of a mineral, its chemical form and the antibiotic involved can change the result, so a class mechanism cannot supply an exact effect size for this pair.
Does the label give a copper schedule?
Its oral instructions explicitly name magnesium and aluminum antacids, iron, and zinc- or iron-containing multivitamins. The two-hour-before or six-hour-after direction belongs to those listed products. The source does not identify a separately verified copper schedule. A pharmacist can decide whether a precaution is appropriate for the actual product and treatment.
Does a multivitamin change the question?
A copper-containing multivitamin may also contain zinc or iron. If it does, the named mineral precautions can apply to those ingredients even when copper itself has limited direct evidence. Keeping each ingredient visible prevents an uncertain copper question from hiding a clearer interaction involving another component of the same tablet.
What should I bring to the pharmacist?
Provide the full supplement panel, copper amount, dosing frequency and the delafloxacin formulation. The goal is a workable plan based on the real exposure. Limited evidence should not be read as proof that no interaction exists, but it also does not justify saying that copper definitely lowers antibiotic levels or that a measured reduction from another medicine applies here.
Evidence and practical considerations
Absorption & effectiveness
There is not enough exact-pair clinical evidence in the checked sources to say that copper supplements reduce oral delafloxacin absorption or require a particular interval. Copper belongs to a group of metals that can bind medicines, but that possibility alone does not establish a clinical interaction with this antibiotic.
- Exact scope
- oral copper supplements, with exact salt and combination ingredients retained with oral delafloxacin meglumine tablets, 450 mg active delafloxacin equivalent
- Medication form and route
- oral
- Timing or duration
- Direct clinical dose, treatment duration and spacing interval not established.
What remains uncertain
- The current delafloxacin label names several other minerals but not copper specifically. Targeted original-source searches did not locate a copper-delafloxacin human interaction trial.
Factors that may matter: exact salt and dose; order and interval between oral doses; combination-product ingredients; oral versus nonoral route.
Read the supporting source summaries
Source 1: regulatory product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Adults prescribed oral BAXDELA tablets; injection instructions kept separate.
Take tablets at least 2 hours before or 6 hours after magnesium/aluminum antacids, iron and zinc/iron multivitamins. Patient instructions also name Mg, Al, Fe and Zn products. Tablets can be taken with or without food. Calcium/magnesium solutions are prohibited in the same IV line; that is not an oral calcium trial.
How this applies: Explicit active-moiety equivalence supports oral meglumine tablets under parent RxCUI 1927663. Oral and IV instructions are not interchangeable. Article-specific counterparty: oral copper supplements, with exact salt and combination ingredients retained.
No individual mineral effect size or direct oral copper/calcium trial is supplied. Label guidance is not an independent human interaction experiment.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Exact-drug product guidance and original research checked; complete private article prepared with evidence limitations and current-claim adjudication. | |
| Research summary published |
Article revision: d7f7dcb61ca9c164
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.